News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Year202520242023 MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Fulltext search Search Vall d'Hebron highlights the potential of synbiotics to control irritability 22/07/2024 Genetic basis of ADHD and autism spectrum disorder impacts on school performance 31/05/2024 Vall d'Hebron develops a system to facilitate bladder washing after surgery 08/04/2024 Vall d’ Hebron renews its commitment to combat gender violence, coinciding with 25-N 23/11/2023 MiMARK Diagnostics raises 1 M€ 07/06/2023 A genetic study indicates that ADHD is associated with lower life expectancy 09/05/2023 Largest genetic study in ADHD identifies new genome regions associated with the disorder 24/02/2023 Dr. Albert Carrión receives an award from the UB-HUB Chair on ABEX Robotic Surgery 27/01/2023 Four Vall d’Hebron mental health projects awarded in the 2021 TV3 La Marató charity event 03/11/2022 The fifth “Solidarity Kerchief” initiative promotes research into women’s cancers 18/10/2022 We test a new treatment that allows kidney transplantation in inoperable patients so far 25/08/2022 Different genes would explain the higher severity of acute kidney injury in males 08/06/2022 Dr Amanda Rodríguez presents her book 'Siente lo que comes' 05/04/2022 New study shows the relationship between insomnia and ADHD improvement 03/03/2022 New report with the collaboration of Vall d’Hebron calls for clearer definition of treatment-resistant depression 15/12/2021 Vall d'Hebron studies the effectiveness of online interventions for cannabis addiction in young people 07/12/2021 Families with transplanted children feel more understood due to the widespread use of prevention measures, such as masks 15/09/2021 Vall d'Hebron participates in a study that identifies 33 new genetic variants associated with bipolar disorder 16/05/2021 A pioneering study by Vall d'Hebron demonstrates the efficacy of a new recovery protocol for patients with advanced ovarian cancer 15/04/2021 Vall d’Hebron enrolls the first patient in a Phase IIb clinical trial by Oryzon for Borderline Personality Disorder 28/03/2021 Pagination 1 2 Next › Next page Last » Last page